Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

BRITAIN HEALTH GLAXO
RTRDJ5
January 17, 2000
Sir Richard Sykes (L), Chairman of Glaxo Wellcome takes a closer look at the name board as Jean-Pierre...
London, United Kingdom of Great Britain
SIR RICHARD SYKES AND JEAN-PAIERRE GARNIER CHECK NEW COMPANY NAMEERENCE.
Sir Richard Sykes (L), Chairman of Glaxo Wellcome takes a closer look at the name board as Jean-Pierre Garnier Chief Executive Officer elect of Smithkline Beecham looks on following a news conference January 17 on the proposed merger of Glaxo Wellcome and Smithkline Beecham. The two British companies, which tried and failed to merge two years ago, said the deal, worth #114 billion, would give the the scientific and financial clout to be the most efficient drug discovery and marketing machine in the industry.

DJM/PS/ME
Sort by
Display
Items per page
Page
of 1